Details for New Drug Application (NDA): 005151
✉ Email this page to a colleague
NDA 005151 describes PERCORTEN, which is a drug marketed by Novartis and is included in two NDAs. Additional details are available on the PERCORTEN profile page.
The generic ingredient in PERCORTEN is desoxycorticosterone acetate. There are two drug master file entries for this compound. Additional details are available on the desoxycorticosterone acetate profile page.
The generic ingredient in PERCORTEN is desoxycorticosterone acetate. There are two drug master file entries for this compound. Additional details are available on the desoxycorticosterone acetate profile page.
Summary for 005151
| Tradename: | PERCORTEN |
| Applicant: | Novartis |
| Ingredient: | desoxycorticosterone acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 005151
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | PELLET;IMPLANTATION | Strength | 125MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
